CervoMed Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
CervoMed Inc. (CRVO) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $11.56 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2025-03-17
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $11.56M.
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00; Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed $12.41M.
- 2023-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2023-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $11.77M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2024-03-31 | $11.56M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 | $12.41M 10-Q · filed 2024-05-14 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $11.77M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $11.56M 10-Q · filed 2024-08-09 | |
| 2022-12-31 | $12.41M 10-K · filed 2025-03-17 | |
| 2022-09-30 | $12.41M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $12.41M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $10.03M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |